Access to the text (HTML) Access to the text (HTML)
PDF Access to the PDF text

Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 61, n° 5
pages 865-867 (novembre 2009)
Doi : 10.1016/j.jaad.2009.08.023
Dialogues in Dermatology

Imiquimod use in the treatment of lentigo maligna

Jacqueline M. Junkins-Hopkins, MD
Based on the dialogue “Imiquimod for the treatment of melanoma” between M. Shane Chapman, MD, and Stuart Brown, MD 
Division of Dermatopathology and Oral Pathology, Department of Dermatology, Johns Hopkins Medical Institutions, Baltimore, Maryland 

Reprint requests: Jacqueline M. Junkins-Hopkins, MD, Division of Dermatopathology and Oral Pathology, Department of Dermatology, Johns Hopkins Medical Institution, 600 N Wolfe St, Blalock Bldg, Rm #907, Baltimore, MD 21287.

Dialogues in Dermatology, a monthly audio program from the American Academy of Dermatology, contains discussions between dermatologists on timely topics. Commentaries from Dialogues Editor-in-Chief Jacqueline M. Junkins-Hopkins, MD, are provided after each discussion as a topic summary and are provided here as a special service to readers of the Journal of the American Academy of Dermatology .

The full text of this article is available in PDF format.

 The statements and opinions expressed in this commentary are those of the Editor-in-Chief of Dialogues in Dermatology.
 Funding sources: None.
 Conflicts of interest: Dr Chapman is supported by 3M with grants and is a consultant with Graceway. Dr Brown is a speaker for and received honoraria from Dermik, Galderma, Novartis, and Stiefel. Dr Junkins-Hopkins declared no conflicts of interest.

Top of the page

© 2009  American Academy of Dermatology, Inc.@@#104156@@
EM-CONSULTE.COM is registrered at the CNIL, déclaration n° 1286925.
As per the Law relating to information storage and personal integrity, you have the right to oppose (art 26 of that law), access (art 34 of that law) and rectify (art 36 of that law) your personal data. You may thus request that your data, should it be inaccurate, incomplete, unclear, outdated, not be used or stored, be corrected, clarified, updated or deleted.
Personal information regarding our website's visitors, including their identity, is confidential.
The owners of this website hereby guarantee to respect the legal confidentiality conditions, applicable in France, and not to disclose this data to third parties.
Article Outline
You can move this window by clicking on the headline